Gene · 2303
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Navigating the Multiverse of Antisense RNAs: The Transcription- and RNA-Dependent Dimension. | Noncoding RNA | 2022 | 36412909 | PubTator, text mining | PubMed |
| Glis1 and oxaloacetate in nucleus pulposus stromal cell somatic reprogramming and survival. | Front Mol Biosci | 2022 | 36406265 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation. | Front Immunol | 2022 | 36405728 | PubTator, text mining | PubMed |
| Role of Cancer Stem-like Cells in the Process of Invasion and Mesenchymal Transformation by a Reconstituted Triple-negative Breast Cancer Cell Population Resistant to p53-induced Apoptosis. | Acta Histochem Cytochem | 2022 | 36405550 | PubTator, text mining | PubMed |
| Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma. | Genome Med | 2022 | 36404344 | PubTator, text mining | PubMed |
| Acquired lymphedema: Molecular contributors and future directions for developing intervention strategies. | Front Pharmacol | 2022 | 36386144 | PubTator, text mining | PubMed |
| Human multilineage pro-epicardium/foregut organoids support the development of an epicardium/myocardium organoid. | Nat Commun | 2022 | 36379937 | PubTator, text mining | PubMed |
| Loss of the Nuclear Envelope Protein LAP1B Disrupts the Myogenic Differentiation of Patient-Derived Fibroblasts. | Int J Mol Sci | 2022 | 36362402 | PubTator, text mining | PubMed |
| The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. | Int J Mol Sci | 2022 | 36362359 | PubTator, text mining | PubMed |
| Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer. | Cancers (Basel) | 2022 | 36358843 | PubTator, text mining | PubMed |
| Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness. | Cancers (Basel) | 2022 | 36358747 | PubTator, text mining | PubMed |
| Identification of Heme Oxygenase-1 as a Putative DNA-Binding Protein. | Antioxidants (Basel) | 2022 | 36358506 | PubTator, text mining | PubMed |
| Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells. | Cell Death Discov | 2022 | 36344487 | PubTator, text mining | PubMed |
| PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer. | Front Endocrinol (Lausanne) | 2022 | 36329884 | PubTator, text mining | PubMed |
Haploinsufficiencies of FOXF1, FOXC2 and FOXL1 genes originated from deleted 16q24.1q24.2 fragment related with alveolar capillary dysplasia with misalignment of pulmonary veins and lymphedema-distichiasis syndrome: relationship to phenotype. | Mol Cytogenet | 2022 | 36329475 | PubTator, text mining | PubMed |
| Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review. | Elife | 2022 | 36326232 | PubTator, text mining | PubMed |
| Mechanisms governing target search and binding dynamics of hypoxia-inducible factors. | Elife | 2022 | 36322456 | PubTator, text mining | PubMed |
| Is Epithelial-Mesenchymal Transition a New Roadway in the Pathogenesis of Oral Submucous Fibrosis: A Comprehensive Review. | Cureus | 2022 | 36321045 | PubTator, text mining | PubMed |
| FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis. | Nat Commun | 2022 | 36319643 | PubTator, text mining | PubMed |
| Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial-Mesenchymal transition. | Front Oncol | 2022 | 36313710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2303/papers?page=20